Yi Qian

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers43 papers

Sort

By YearBy Citation

Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea

Siin Kim, Sola Han, Pratik P Rane,Yi Qian,Zhongyun Zhao,Hae Sun Suh

PloS one, no. 1 (2020)

WOSBibtex

A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective

Steve Ryder,Kathleen Fox, Pratik Rane,Nigel Armstrong, Ching-Yun Wei,Sohan Deshpande,Lisa Stirk,Yi Qian,Jos Kleijnen

PharmacoEconomics, pp.1-25, (2019)

Bibtex

Estimating Years of Life Lost Due to Cardiovascular Disease in Japan

Hidenori Arai, Kalliopi Mortaki, Pratik Rane, Casey Quinn,Zhongyun Zhao,Yi Qian

Circulation journal : official journal of the Japanese Circulation Society, (2019)

WOSBibtex

Understanding the Patient Perception of Statin Experience: A Qualitative Study

Michal Vrablik,Alberico L Catapano, Olov Wiklund,Yi Qian, Pratik Rane, Alyson Grove,Mona L Martin

Advances in Therapy, no. 10 (2019): 2723-2743

WOSBibtex

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

Hyungtae Kim, Siin Kim, Sola Han, Pratik P Rane,Kathleen M Fox,Yi Qian,Hae Sun Suh

BMC Public Health, no. 1 (2019): 1-11

WOSBibtex

Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease

Alanna M Chamberlain,Sarah S Cohen,Susan A Weston,Kathleen M Fox, Pin Xiang,Jill M Killian,Yi Qian

AMERICAN JOURNAL OF CARDIOLOGY, no. 11.0 (2019): 1739-1744

WOSBibtex

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population

Suying Li,Yi Peng,Xinyue Wang,Yi Qian, Pin Xiang, Sally W Wade,Haifeng Guo, J Antonio G Lopez,Charles A Herzog, Yehuda Handelsman

Clinical cardiology, no. 3 (2019): 391-399

WOSBibtex

Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-Based Study in South Korea

Siin Kim,Hyungtae Kim,Eunju Kim, Sola Han, Pratik P Rane, Kathleen M Fox,Zhongyun Zhao,Yi Qian,Hae Sun Suh

Clinical Therapeutics, no. 6 (2018): 940-951.e7

WOSBibtex

Real World Disease Burden In Patients With Dyslipidemia With/Without Diabetes Mellitus Or Ascvd In China

Pp Rane, J Shepherd,Z Zhao, H Bailey, N Williams,Y Qian

Value in Health, (2018)

Bibtex

Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom

Yi Qian,Jorge Arellano,Francesca Gatta,Guy Hechmati,A. Brett Hauber,Ateesha F. Mohamed,Amit Bahl,Roger von Moos,Jean-Jacques Body

BMC HEALTH SERVICES RESEARCH, (2018)

Bibtex

Low-Density Lipoprotein Cholesterolgoal Attainment Based on 2015 Korean Dyslipidemia Guidelines

Eunju Kim, Sola Han, Pp Rane,Y Qian, Hae Sun Suh

Value in Health, (2018)

Bibtex

P2320Lack of low-density lipoprotein cholesterol (LDL-C) goal attainment among high-risk patients using high or moderate intensity statin therapy in Germany

K.M. Fox,Karel Kostev, C. Von Vultee, M. Hatz, M.-H. Tai,Y. Qian

EUROPEAN HEART JOURNAL, no. SUPnan (2017): 463-463

Bibtex

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins

Kathleen M Fox,Ming-Hui Tai,Karel Kostev, Maximilian Hatz,Yi Qian,Ulrich Laufs

Clinical research in cardiology : official journal of the German Cardiac Society, no. 5 (2017)

Cited by3WOSBibtex

Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy

Saurabh P Nagar, Pratik P Rane, Kathleen M Fox,Juliana Meyers,Keith Davis, Anne Beaubrun, Hyoe Inomata,Yi Qian,Kouji Kajinami

Circulation journal : official journal of the Japanese Circulation Society, (2017)

Cited by3WOSBibtex

Clinician interview results about the experiences of their patients who report side effects with statin treatment

Michal Vrablik,Alberico Catapano, Olav Wiklund, Alyson Grove, Talia Miller,Kelly Mccarrier,Yi Qian, Pratik Rane,Mona Martin

ATHEROSCLEROSIS, (2017): E247-E247

WOSBibtex

Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context

Peter P Toth,Mark Danese,Guillermo Villa,Yi Qian, Anne Beaubrun, Armando Lira,Jeroen P Jansen

Journal of medical economics, no. 6 (2017): 555-564

Cited by19WOSBibtex

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Gregg C Fonarow,Anthony C Keech,Terje R Pedersen,Robert P Giugliano,Peter S Sever,Peter Lindgren,Ben van Hout,Guillermo Villa,Yi Qian,Ransi Somaratne,Marc S Sabatine

JAMA CARDIOLOGY, no. 10 (2017): 1069-1078

Cited by34WOSBibtex

Abstract 13866: Cardiovascular Event Rates After Myocardial Infarction or Ischemic Stroke in Older Medicare Patients

Suying Li,Yi Peng,Xinyue Wang,Yi Qian, Pin Xiang, Sally W Wade,Haifeng Guo, J. Antonio G Lopez, Yehuda Handelsman,Charles A Herzog

Circulation, (2017)

Bibtex

Utilization Patterns of Lipid-Lowering Therapies in Patients at High Risk for or with Atherosclerotic Cardiovascular Disease: A Population-Based Study in South Korea

Hae Sun Suh, Siin Kim,Hyungtae Kim,Eunju Kim, Sola Han, Pp Rane, Kathleen M. Fox,Z Zhao,Y Qian

Value in Health, no. 9 (2017)

Bibtex

Burden Of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic Cardiovascular Disease (ASCVD) And The Impact Of Reducing Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Latin American Countries

D Vianna, M Habib, G Villa,Y Qian, P Xiang, Luciana Bahia, Fp Alves, Me Alva, A Ruiz Morales, J Verdejo Paris

Value in Health, no. 9 (2017)

Bibtex

View All

Base Info Papers Patents Projects

Yi QianBinding

Papers43 papers

Yi Qian